methylcobalamin with tirzepatide Tirzepatide/B12 Injectable (68mg/8mg) Preserving Muscle While Losing Fat:

A study in July 2024 by researchers at Mass Eye and Ear in Boston found that people taking semaglutide for type 2 diabetes or weight loss had a higher risk of developing nonarteritic anterior ischemic optic neuropathy, an eye condition that can cause blindness, than people taking medications other than GLP-1 drugs for diabetes or obesity

Given the significant benefits for patients with CKD, the FDA approved a new indication for semaglutideto reduce the risk of estimated glomerular filtration rate decline, end-stage kidney disease, and cardiovascular death in patients with T2D and CKD

Both aerobic exercise and strength training have been shown to enhance GLP 1 hormone levels

In healthy populations with adequate levels, the evidence tends to be more heterogeneous, so absolute conclusions should be avoided